Navigation Links
Late Breaking Data Released at ADA Showed that the Investigational,Use of Januvia and Metformin as Initial Combination Therapy,Provided Significant Glucose Lowering Efficacy over 54 Weeks in,Patients with Type 2 Diabetes

e avoided in patients with evidence of hepatic disease. Before initiation of therapy with JANUMET and at least annually thereafter, renal function should be assessed and verified as normal. Patients should be warned against excessive alcohol intake while receiving JANUMET. Patients may require discontinuation of JANUMET and temporary use of insulin during periods of stress and decreased intake of fluids and food such as may occur with fever, trauma, infection or surgery. Patients previously controlled on JANUMET who develop laboratory abnormalities or clinical illness should be evaluated promptly for evidence of ketoacidosis or lactic acidosis. The reported incidence of lactic acidosis in patients receiving metformin hydrochloride is very low (approximately 0.03 cases/1000 patient-years, with approximately 0.015 fatal cases/1000 patient-years). When lactic acidosis occurs, it is fatal in approximately 50 percent of cases.

Expanding clinical development program for sitagliptin family

Merck's clinical development program for sitagliptin is robust and continues to expand with 47 studies completed or under way, and nine more studies set to begin this year. There have been more than 7,600 patients in the Company's clinical studies with about 4,700 of these patients, being treated with sitagliptin. Additionally, about 1,900 patients have been treated with sitagliptin for more than a year.

About Merck

Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The Company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service. For more information, visit www.merck.co
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. VeroScience Late-Breaking Abstract on Cycloset (A Quick Release Formulation of Bromocriptine Mesylate) Accepted for Poster Presentation at American Diabetes Association 67th Scientific Sessions
2. Pilot Phase 3 Results of NovaCardias KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
3. Breaking Multi-Center Study: Masimo SET Pulse Oximetry Technology Shown to Significantly Lower Instances of Severe Retinopathy of Prematurity in Extremely Low Birth Weight Infants
4. Bentley Late Breaking Abstract Accepted for Poster Presentation at American Diabetes Association Scientific Sessions
5. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
6. Everest Data on Short- and Long-Term Use of Otsukas Investigational Novel Treatment, Tolvaptan, Published in Journal of the American Medical Association and Featured in ACCs Late Breaking Clinical Trials
7. Lupus Foundation of America Statement on Results for Clinical Study of CellCept Released by Aspreva Pharmaceutical Company
8. An Investigational Study Released at ADA Showed that Initial Combination Therapy with Januvia (sitagliptin) and Metformin Led to Improvement in Markers of Beta Cell Function in Patients with Type 2 Diabetes
9. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
10. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. New Anti-Rejection Medication 6-Month Results for Heart Transplant Recipients to Be Released at International Heart and Lung Transplant Meeting
Post Your Comments:
(Date:3/15/2010)... Adamas Pharmaceuticals, Inc., a privately held ... animal studies and in vitro ... (TCAD) therapy is superior relative to double combinations ... avian influenza viruses. Results of these studies were ... the XII International Symposium on Respiratory Viral Infections ...
(Date:3/14/2010)... , March 14 Results were presented today on behalf ... patients with diabetes that evaluated cardiovascular outcomes in three distinct studies – glycemic ... ACCORD Lipid study, Abbott issued the following statement: , ... ... ...
(Date:3/14/2010)... ATLANTA , March 14 /PRNewswire-FirstCall/ ... American College of Cardiology,s 59th annual scientific ... Valve Edge-to-Edge REpair STudy) trial demonstrated that ... primary safety and effectiveness endpoints(1), suggesting that ... an important treatment option for patients with ...
Breaking Medicine Technology:Adamas Pharmaceuticals' TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models 2Adamas Pharmaceuticals' TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models 3Adamas Pharmaceuticals' TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models 4Adamas Pharmaceuticals' TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models 5Adamas Pharmaceuticals' TCAD Therapy Demonstrates Broad Spectrum Activity Against Susceptible and Resistant Strains of Influenza in Animal Models 6Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use 2Abbott Statement: ACCORD Lipid Results Support Treatment Guidelines for Fibrate Use 3New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition 2New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition 3New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition 4New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition 5New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition 6New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition 7New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition 8New Data Demonstrates Abbott's Investigational MitraClip(R) System Has Potential to be a Valuable Treatment Option for Patients With Mitral Regurgitation, the Most Common Heart Valve Condition 9The Right Colorectal Cancer Test for the Right Patient 67818 1The Right Colorectal Cancer Test for the Right Patient 67818 2The Right Colorectal Cancer Test for the Right Patient 67818 3The Right Colorectal Cancer Test for the Right Patient 67818 4The Right Colorectal Cancer Test for the Right Patient 67818 5The Right Colorectal Cancer Test for the Right Patient 67818 6Bally Total Fitness Launches Music Focused Marketing Platform 67814 1Bally Total Fitness Launches Music Focused Marketing Platform 67814 2Bally Total Fitness Launches Music Focused Marketing Platform 67814 3AMA Honors Washington State Secretary of Health With Top Government Service Award 67810 1AMA Honors Washington State Secretary of Health With Top Government Service Award 67810 2AMA Honors Washington State Secretary of Health With Top Government Service Award 67810 3
(Date:3/15/2010)... that may help fill a critical need in stem ... School of Medicine have demonstrated that skin cells found ... pluripotency, where they have characteristics similar to human embryonic ... of cell in the human body. The study is ... next issue of the journal Cellular Reprogramming , ...
(Date:3/15/2010)... Normal individuals who scored high on a measure of ... to a brain imaging study by researchers at Vanderbilt ... in the brain,s reward system that may underlie vulnerability ... study in the current issue of the journal ... on Drug Abuse (NIDA), a component of the National ...
(Date:3/15/2010)... BRUNSWICK, N.J. , March 15 ... statewide female-specific AIDS service organization, has launched "I Stand ... intended to mobilize families, individuals, corporations, social service agencies, ... up for the lives of women in NJ. At ... proportion of women living with AIDS in the nation. ...
(Date:3/15/2010)... [NLA] was recently featured by Lloyd,s of London in their electronic market ... insurance market. The article featuring New Life was in response to the recent press ... introduce the nations first in vitro fertilization insurance program. , ... ... , ...
(Date:3/15/2010)... Fla. (March 15, 2010)Patient selection is key ... interventional radiologists in individuals with painful osteoporotic ... to conventional medical therapyto be effective and ... than 1,500 persons who were followed over ... radiologist and other medical experts in treating ...
Breaking Medicine News(10 mins):Health News:Amniotic fluid cells more efficiently reprogrammed to pluripotency than adult cells 2Health News:Amniotic fluid cells more efficiently reprogrammed to pluripotency than adult cells 3Health News:Impulsive-antisocial personality traits linked to a hypersensitive brain reward system 2Health News:Impulsive-antisocial personality traits linked to a hypersensitive brain reward system 3Health News:For Women's History Month New Jersey Women and AIDS Network Launches 'I Stand With NJWAN' HIV Action and Awareness Campaign 2Health News:For Women's History Month New Jersey Women and AIDS Network Launches 'I Stand With NJWAN' HIV Action and Awareness Campaign 3Health News:Lloyd's of London News Features New Life Agency, Inc. 2Health News:Lloyd's of London News Features New Life Agency, Inc. 3Health News:Vertebroplasty for patients with osteoporosis provides effective pain relief 2Health News:Vertebroplasty for patients with osteoporosis provides effective pain relief 3
... teens. A report also disclosed that the recent sharp increases ... use decreased, and a gradual decline in use of inhalants ... ,These important declines in teen smoking did not ... have been making concerted efforts to bring down the unacceptably ...
... ensure the best outcome for the patient. This should ... avoid the side effects relating to these drugs. Several ... at Texas University it is necessary to find out ... differences between these drugs when it comes to reducing ...
... ‘Cyber City’ in Hyderabad, Andhra Pradesh chief minister Chandrababu ... up a ‘Pharma City’ in the port town of ... the state government hopes to attract global pharmaceutical companies ... the post-patent regime by 2005. The ‘Pharma City’ will ...
... to French researchers there is no obvious medical explanation ... patients during cardiac arrest. The near death experience (NDE) ... years.// It involves a feeling of disconnection from the ... cardiac arrest - and often progress down a tunnel ...
... demand for a new vaccine against childhood pneumonia, meningitis ... the country. Meanwhile, doctors are directing the supplies they ... of infection, such as those with sickle cell anemia, ... immune system. ,PREVNAR fights the bacterium streptococcus pneumoniae, ...
... despite a diet rich in butter and other fats, has ... another staple of the French diet. //Scientists say they have ... pigments known as polyphenols. ,Polyphenols inhibit the ... arteries. Polyphenols in red wine decreases the amount of the ...
Other Medicine News:
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: